SCHEMBL22818278

SCHEMBL22818278

c1ccc(-c2ccc(-c3cccc4oc5c6ccccc6c(N(c6ccccc6-c6ccccc6)c6cccc7c6oc6ccccc67)cc5c34)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 3/20 0.41
▸ GGPS1 O95749 1/20 0.34
▸ CDC14B O60729 2/20 0.33
▸ CDC14A Q9UNH5 2/20 0.33
▸ PRKDC P78527 4/20 0.32
▸ PTGES2 Q9H7Z7 1/20 0.32
▸ PLA2G2A P14555 4/20 0.32
▸ PLA2G4A P47712 4/20 0.32
▸ PIM1 P11309 1/20 0.31
▸ CSNK2A2 P19784 1/20 0.31
▸ CSNK2B P67870 1/20 0.31
▸ PIM3 Q86V86 1/20 0.31
▸ PIM2 Q9P1W9 1/20 0.31
▸ PLA2G10 O15496 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ CSF1R P07333 1/20 0.30
▸ PDGFRB P09619 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ KIT P10721 1/20 0.30
▸ FLT3 P36888 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22818065 0.98 ALOX5 (0.40) ALOX5GGPS1CDC14BCDC14APRKDC
SCHEMBL22818084 0.95 ALOX5 (0.40) ALOX5GGPS1CDC14BCDC14APRKDC
SCHEMBL22818149 0.93 ALOX5 (0.39) ALOX5GGPS1CDC14BCDC14APRKDC
SCHEMBL22817773 0.92 ALOX5 (0.41) ALOX5GGPS1CDC14BCDC14APRKDC
SCHEMBL22818459 0.92 ALOX5 (0.41) ALOX5GGPS1CDC14BCDC14APRKDC
SCHEMBL15851667 0.92 ALOX5 (0.43) ALOX5GGPS1CDC14BCDC14APRKDC
SCHEMBL22818436 0.92 ALOX5 (0.40) ALOX5GGPS1PRKDCPTGES2MEN1
SCHEMBL22818390 0.91 ALOX5 (0.38) ALOX5GGPS1CDC14BCDC14APRKDC
SCHEMBL15852068 0.91 ALOX5 (0.39) ALOX5GGPS1CDC14BCDC14APRKDC
SCHEMBL15852179 0.90 ALOX5 (0.42) ALOX5GGPS1CDC14BCDC14APRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LT MATERIALS CO., LTD. (KR) 2020-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same CRY1, CRY2, PER2 ALOX5 1385/4885GGPS1 598/4885CDC14B 589/4885
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, PER2 ALOX5 1385/4885GGPS1 598/4885CDC14B 589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback